Open AccessBarrett’s Esophagus after Bimodality Therapy in Patients with Esophageal Adenocarcinoma
Author(s) -
Fatemeh G. Amlashi,
Xuemei Wang,
Raquel E. Davila,
Dipen M. Maru,
Manoop S. Bhutani,
Jeffrey H. Lee,
Brian Weston,
Dılşa Mızrak Kaya,
Maria Vassilakopoulou,
Kazuto Harada,
Mariela A. Blum Murphy,
David C. Rice,
Wayne L. Hofstetter,
Marta Davila,
Quynh Nguyen,
Jaffer A. Ajani
Publication year - 2018
Publication title -
oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.987
H-Index - 98
eISSN - 1423-0232
pISSN - 0030-2414
DOI - 10.1159/000488489
Subject(s) - medicine , gastroenterology , esophagus , barrett's esophagus , adenocarcinoma , dysplasia , esophageal disease , surgery , cancer
Barrett's esophagus (BE) may be present in patients with esophageal adenocarcinoma (EAC) after bimodality therapy (BMT). There is no specific guidance for follow-up of these patients with regard to the presence of BE or dysplasia. In this study, we assessed the outcomes of patients who, after BMT, had BE and those who did not.